Origin
New accelerator entry · 2026-02-04 · the record
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.
Origin is a Y Combinator company in the Winter 2026 batch. Its directory entry describes it as: AI and Data for Cancer Therapeutics. The founders listed are Yash Rathod (Founder/CEO), Malhar Bhide (Founder/CTO) (Y Combinator directory entry, February 4, 2026).
Sell to companies like Origin? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New accelerator entry · 2026-02-04 · the record
Pitching, partnering or investing alongside them? See who really runs and owns Origin.
Free to see. No signup.
More on Origin and the records around it.
Same batch, Healthcare first.
Get an email when Origin changes status, grows its team or files a funding notice. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when Origin raises, hires or launches. No email unless you switch it on.
Watch Origin →Get the full cited report on Origin
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Origin: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Creating the largest patient-derived cancer single-cell dataset for licensing to pharmaceutical and AI companies. These datasets are unique as they screen the effects of various drugs and genetic medicines under the control of our DNA switches.
Checked away from the directory entry. Neither line below comes from the company's Y Combinator page.
What if we made as many cancer drugs next year as we have in the last decade?
The title and description the site itself served, answering 200. Not a cached copy and not the company's directory entry — what was live when we asked.
Counted only where a thread links to this company's own site, announces it by name on that forum, or names it beside its own Y Combinator batch. A thread whose title merely carries the words is not counted — a name is not an identifier. More may exist than the one page of results read here. Hacker News is not us, and nothing above is our opinion of the company.
Founders, titles and bios as the company published them. Photographs are our own copies of the ones on that record, so they do not break when the original link expires.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on Origin: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Origin covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist OriginYou get an alert in MentionFox the next time this company shows up.
If you're behind Origin: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. GetFoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry, from the company's own site, read directly on 2026-09-27 (origin.bio), and from Hacker News, where 1 thread met the matching rule stated beside the count.
Each opens in a new tab, filled in for Origin. With no account yet, you sign up free and land on the result.
Share the news. Sharing needs no account.

https://mentionfox.com/funding/yc-origin-bio